2 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 2, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow University of Warwick: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency 400mg progesterone Callavid - 2hr wear, Cyclogest 400 mg, 400mg progesterone Callavid - 3hr wear - Luteal Phase Insuffiency, Progesterone Delivery | Phase 1 | Recruiting | Calla Lily Clinical Care Ltd | 20 | 2026-04-20 | 2026-09-10 |
| Parents Resources for Decreasing the Incidence of Change Triggered Temper Outbursts Visual Scheduling, signalling change - Child Behavior | Phase 1 | Completed | Queen's University, Belfast | 80 | 2015-01-01 | 2020-02-17 |
| Healthy Aging Through Functional Food Glyoxalase 1 (Glo1) inducer, Placebo - Glucose Intolerance, Aortic Stiffness | Phase 1 / Phase 2 | Completed | University of Warwick | 32 | 2014-05-01 | 2017-03-06 |
Aneurysm (1) · Autistic Disorder (1) · Child Behavior (1) · Down Syndrome (1) · Fragile X Syndrome (1) · Glucose Intolerance (1) · Intellectual Disability (1) · Prader-Willi Syndrome (1)
Lactoylglutathione Lyase (1) · Progesterone (1) · Resveratrol (1) · hesperetin (1)
United Kingdom (3)
Kate Woodcock, PhD (1) · Martin O Weickert, MD (1) · Paul J Thornalley, BSc PhD (1)